Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 18, 2022

Assessment of anti-inflammatory and antioxidant activity of quercetin–rutin blend (SophorOx™) – an invitro cell based assay

  • Devanand Shanmugasundaram ORCID logo EMAIL logo and James Martin Roza

Abstract

Objectives

Quercetin & Rutin, are bioactive compounds that are widely used for various therapeutic properties. There’s been growing interest in the biological activities of these polyphenols belonging to the class of flavonoids known to have various health benefits. Quercetin is now popularly recognized as a phytochemical remedy for a plethora of disease groups such as metabolic syndrome (more specifically diabetes), obesity/weight management and mood disorders. Due to its unique chemical structure, the most prominent property of Quercetin is probably its antioxidant capability. It acts as a free radical scavenger to form resonance-stabilized phenoxyl radicals. Certain in vitro studies have also shown quercetin to have anti-viral, anti-carcinogenic and platelet aggregation properties. Rutin has also been shown to exert diverse biological effects such as anti-tumor activities, reduction of inflammatory cytokines and antimicrobial activities. The current study was designed to further confirm the antioxidant and anti-inflammatory property of a Quercetin–Rutin blend (SophorOx™).

Methods

The analysis was performed in a cell-based assay using RAW 264.7 macrophage cell line. SophorOx™ was screened for cytotoxicity using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to obtain optimum concentrations for experimental assays. SophorOx™ was measured for pro-inflammatory cytokine levels (TNF-α & IL-6) and nitric oxide (NO) levels. Additionally, ROS (reactive oxygen species) levels in RAW cells were estimated using a cell-permeant reagent 2′7′-dichlorofluorescein diacetate (DCFH-DA).

Results

SophorOx™ at 10 µM concentration, exhibited an anti-inflammatory property with significant inhibitory levels of TNF-α (∼28.25%) and IL-6 (∼32.25%). SophorOx™ at similar concentrations reduced nitric oxide levels to 70.55% in lipopolysaccharide (LPS) stimulated RAW 264.7 cells. Raw 264.7 cells stimulated with LPS exhibited a significant increase in intracellular ROS and this was significantly reduced (78.2% reduction) at lower concentrations (0.3 µM) of SophorOx™.

Conclusions

The anti-inflammatory effects of SophorOx™ were investigated in LPS stimulated RAW 264.7 macrophages. Data suggests, that SophorOx™ reduced levels of nitric oxide, intracellular ROS and pro-inflammatory cytokines (TNF-α & IL-6) at low concentrations without affecting the viability of RAW cells. Present invitro trial suggests that SophorOx™ is a potent antioxidant and anti-inflammatory agent and displays a prominent ability to block mediators of oxidative stress and inflammation.


Corresponding author: Devanand Shanmugasundaram, Senior Associate, Compliance & Operations (Toxicology), Vedic Lifesciences Pvt. Ltd., Mumbai, India, Phone: +91 9940478801, E-mail:

Acknowledgments

The authors would like to thank the working staff personnel’s of Vedic Lifesciences and Layn Natural Ingredients for the smooth conduct of the study.

  1. Research funding: None Declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Kaminski, M, Kręgielska, NM, Bogdanski, P. Determination of the popularity of dietary supplements using google search rankings. Nutrients 2020;12:908.10.3390/nu12040908Search in Google Scholar

2. Ramawat, KG, Dass, S, Mathur, M. The chemical diversity of bioactive molecules and therapeutic potential of medicinal plants. In: Ramawat, KG, editor Herbal drugs: ethnomedicine to modern medicine. Berlin/Heidelberg: Springer; 2009.10.1007/978-3-540-79116-4_2Search in Google Scholar

3. Jain, N, Ramawat, KG. Nutraceuticals and antioxidants in prevention of diseases. In: Ramawat, K, Mérillon, JM, editors Natural Products. Berlin, Heidelberg: Springer; 2013.10.1007/978-3-642-22144-6_70Search in Google Scholar

4. Chen, YC, Shen, SC, Lee, WR, Hou, WC, Yang, LL, Lee, TJ. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide-induced inducible NOS and cyclooxygenase‐2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 2001;82:537–48. https://doi.org/10.1002/jcb.1184.Search in Google Scholar

5. Ganeshpurkar, A, Saluja, AK. The pharmacological potential of rutin. Saudi Pharmaceut J 2017;25:149–64. https://doi.org/10.1016/j.jsps.2016.04.025.Search in Google Scholar

6. Guardia, T, Rotelli, AE, Juarez, AO, Pelzer, LE. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001;56:683–7. https://doi.org/10.1016/s0014-827x(01)01111-9.Search in Google Scholar

7. Xu, D, Hu, MJ, Wang, YQ, Cui, YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 2019;21:1123–4. https://doi.org/10.3390/molecules24061123.Search in Google Scholar PubMed PubMed Central

8. Adefegha, et al.. Quercetin, rutin, and their combinations modulate penile phosphodiesterase-5′, arginase, acetylcholinesterase, and angiotensin-I-converting enzyme activities: a comparative study Stephen A. Comp Clin Pathol 2018:773–80. https://doi.org/10.1007/s00580-018-2664-y.Search in Google Scholar

9. Domitrovic, R, et al.. Differential hepatoprotective mechanisms of Rutin and Quercetin in CCl4-intoxicated BALB/CN mice. Acta Pharmacol Sin 2012:1260–70.10.1038/aps.2012.62Search in Google Scholar PubMed PubMed Central

10. Song, J, et al.. Comparison of antioxidant and anti-inflammatory activity of Quercetin, isoquercitrin and Rutin against alcohol-induced liver injury in HepG2 Cells Biochemistry and Molecular Biology; 2018.10.1096/fasebj.2018.32.1_supplement.670.60Search in Google Scholar

11. Li, P, Callery, PS, Gan, LS, Balani, SK. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 2007;35:1203–8. https://doi.org/10.1124/dmd.106.013904.Search in Google Scholar PubMed

12. Lee, HN, Shin, SA, Choo, GS, Kim, HJ, Park, YS, Kim, BS, et al.. Anti-inflammatory effect of Quercetin and Galangin in LPS-stimulated RAW264.7 macrophages and DNCB-induced atopic dermatitis animal models. Int J Mol Med 2018;41:888–98. https://doi.org/10.3892/ijmm.2017.3296.Search in Google Scholar PubMed PubMed Central

13. Tian, C, et al.. Dose-effect relationship on anti-inflammatory activity on LPS induced RAW264.7 cells and antioxidant activity of Rutin invitro. Acta Poloniae Pharma Drug Res 2019;76:3. https://doi.org/10.32383/appdr/102677.Search in Google Scholar

Received: 2021-12-19
Accepted: 2022-01-30
Published Online: 2022-02-18

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 12.6.2024 from https://www.degruyter.com/document/doi/10.1515/jcim-2021-0568/html
Scroll to top button